Somatic Mutations in Exons 10, 11, and 16 of the RET Protooncogene in Medullary Thyroid Carcinoma Patients
Introduction: Medullary thyroid carcinoma (MTC) comprises nearly 5% of all cases of thyroid cancer (TC). Aberrant activation of RET (rearranged during transfection) signaling via somatic mutations is the basic molecular mechanism of MTC tumorigenicity. In this study, we determined the incidence of R...
Guardado en:
Autores principales: | Elham Shakiba, Mehdi Hedayati, Ahmad Majd, Monireh Movahedi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Zabol University of Medical sciences
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a996ca7460f4e99877fcbeee1b8fc32 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Modifier Role of Common <i>RET</i> Variants in Sporadic Medullary Thyroid Carcinoma
por: Anna Skalniak, et al.
Publicado: (2021) -
A case report of simultaneous medullary and papillary carcinoma of thyroid
por: Ziaolhagh Reza, et al.
Publicado: (2021) -
Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
por: Sun Jung Kim, et al.
Publicado: (2021) -
Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2
por: Anna Reimer Hansen, et al.
Publicado: (2021) -
Somatic Genomic Changes in the Formation of Differentiated Thyroid Carcinoma
por: Vidinov K., et al.
Publicado: (2020)